These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8906605)

  • 21. Short term effects of acute inhibition of the angiotensin-converting enzyme on the renin-angiotensin system and plasma atrial natriuretic peptide in healthy dogs fed a low-sodium diet versus a normal-sodium diet.
    Koch J; Pedersen HD; Jensen AL; Flagstad A; Poulsen K; Bie P
    Zentralbl Veterinarmed A; 1994 Mar; 41(2):121-7. PubMed ID: 8091887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
    McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats.
    Morishita R; Higaki J; Nagano M; Nakamura F; Tomita N; Zhao Y; Mikami H; Miyazaki M; Ogihara T
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):15-20. PubMed ID: 8381736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the renin angiotensin system throughout the normal menstrual cycle.
    Chidambaram M; Duncan JA; Lai VS; Cattran DC; Floras JS; Scholey JW; Miller JA
    J Am Soc Nephrol; 2002 Feb; 13(2):446-452. PubMed ID: 11805174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of urinary angiotensin to challenges of the renin-angiotensin system.
    Boer P; Vos PF; Koomans HA; Rabelink AJ; Beutler JJ; Dorhout Mees EJ
    Clin Chim Acta; 1991 Jun; 199(2):195-204. PubMed ID: 1873917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.
    Hiramatsu K; Yamagishi F; Kubota T; Yamada T
    Am Heart J; 1982 Dec; 104(6):1346-50. PubMed ID: 6293295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study.
    Chalmers JP; Wing LM; West MJ; Bune AJ; Elliott JM; Morris MJ; Cain MD; Graham JR; Southgate DO
    Aust N Z J Med; 1986 Aug; 16(4):475-80. PubMed ID: 3026294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC; Ames MK; Werre S; Atkins CE
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients.
    Sato A; Suzuki Y; Shibata H; Saruta T
    Hypertens Res; 2000 Jan; 23(1):25-31. PubMed ID: 10737132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of enalapril.
    Abrams WB; Davies RO; Gomez HJ
    J Hypertens Suppl; 1984 Dec; 2(2):S31-6. PubMed ID: 6100874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
    Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
    Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats.
    Kokubu T; Ueda E; Ono M; Kawabe T; Hayashi Y; Kan T
    Eur J Pharmacol; 1980 Apr; 62(4):269-75. PubMed ID: 6245897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin-aldosterone system in pregnancy-induced hypertension.
    Israel A; Peceño A
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S36-9. PubMed ID: 10854079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.